Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 257-263, February 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Creaser, E. H.
Right arrow Articles by Scholefield, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Creaser, E. H.
Right arrow Articles by Scholefield, P. G.

The Influence of Dinitrophenol and Fatty Acids on the P32 Metabolism of Ehrlich Ascites Carcinoma Cells

E. H. Creaser and P. G. Scholefield*

( McGill-Montreal General Hospital Research Institute, Montreal, Canada)

Dinitrophenol (DNP) and decanoate acted as uncoupling agents in intact Ehrlich ascites cells. Their effects were exerted very rapidly, and within 5 minutes of their addition to ascites cells all adenosine triphosphate (ATP) and adenosine diphosphate (ADP) was lost from the cells.

In the presence of either DNP or decanoate there was a decrease in the extent of labeling of the ATP plus ADP fraction under both aerobic and anaerobic conditions. It was concluded that both compounds increased the ATPase activity of the ascites cells in addition to acting as uncoupling agents.

In the presence of glucosamine or of 2-deoxyglucose there was an inhibition of P32 incorporation into the adenosine polyphosphates, and this inhibition was reversed on addition of glucose.

* Research Associate of the National Cancer Institute of Canada.

Received 8/31/59.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.